Litcius/Paper detail

Albendazole–ivermectin co-formulation for the treatment of Trichuris trichiura and other soil-transmitted helminths: a randomised phase 2/3 trial

Alejandro Krolewiecki, Stella Kepha, Pedro Fleitas, Lisette van Lieshout, Woyneshet Gelaye, Augusto Messa, Javier Gandasegui, Jaime Algorta, Valdemiro Novela, Áuria de Jesus, Martin Rono, Dawit Degarege, Dereje Bedane, Jusper Mwahanje, Inácio Mandomando, Charles Mwandawiro, Wendemagegn Enbiale, José Muñóz, Alejandro Krolewiecki, Stella Kepha, Pedro Fleitas, Lisette van Lieshout, Woyneshet Gelaye, Augusto Messa, Javier Gandasegui, Jaime Algorta, Valdemiro Novela, Áuria de Jesus, Martin Rono, Dawit Degearege, Dereje Bedane, Jusper Mwahanje, Inácio Mandomando, Charles Mwandawiro, Wendemagegn Enbiale, José Muñóz, José Muñóz, José Muñóz

2025The Lancet Infectious Diseases17 citationsDOI

Topics & Concepts

Trichuris trichiuraIvermectinAlbendazoleTrichurisHelminthsTrichuriasisVeterinary medicineBiologyMedicineEcologyAscariasisZoologyAscaris lumbricoidesParasites and Host InteractionsHelminth infection and controlParasitic Diseases Research and Treatment
Albendazole–ivermectin co-formulation for the treatment of Trichuris trichiura and other soil-transmitted helminths: a randomised phase 2/3 trial | Litcius